Compile Data Set for Download or QSAR
Report error Found 342 Enz. Inhib. hit(s) with all data for entry = 10994
TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509915(US11124497, Compound 497 (Isomer 2) | US11524940, ...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509916(US11124497, Compound 499 | US11524940, Compound 49...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582651(US11524940, Compound 507 (Isomer 1.2))
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582650(US11524940, Compound 507 (Isomer 2.1) | US11524940...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582650(US11524940, Compound 507 (Isomer 2.1) | US11524940...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509924(US11124497, Compound 511 | US11524940, Compound 51...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509925(US11124497, Compound 511 (Isomer 1) | US11524940, ...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582653(US11524940, Compound 507 (Isomer 2.2))
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582654(US11524940, Compound 509)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509928(US11124497, Compound 513 (Isomer 2) | US11524940, ...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509929(US11124497, Compound 515 | US11524940, Compound 51...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509926(US11124497, Compound 511 (Isomer 2) | US11524940, ...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509908(US11124497, Compound 491 | US11124497, Compound 49...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509908(US11124497, Compound 491 | US11124497, Compound 49...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509910(US11124497, Compound 491 (Isomer 2) | US11124497, ...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582638(US11524940, Compound 491 (Isomer 4))
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582679(US11524940, Compound 611)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582680(US11524940, Compound 619)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582677(US11524940, Compound 603a (Isomer 1))
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509944(US11124497, Compound 625 | US11524940, Compound 62...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582684(US11524940, Compound 633)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582681(US11524940, Compound 621)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509947(US11124497, Compound 639 (Isomer 1) | US11524940, ...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582688(US11524940, Compound 639A)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509945(US11124497, Compound 635 | US11524940, Compound 63...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509946(US11124497, Compound 637 | US11524940, Compound 63...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582692(US11524940, Compound 653 (Isomer 1))
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582689(US11524940, Compound 643)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582690(US11524940, Compound 647)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582663(US11524940, Compound 529)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582664(US11524940, Compound 531)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582661(US11524940, Compound 519)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582662(US11524940, Compound 525)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582667(US11524940, Compound 549)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509934(US11124497, Compound 551 | US11524940, Compound 55...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582670(US11524940, Compound 577)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509941(US11124497, Compound 595 | US11524940, Compound 59...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509942(US11124497, Compound 598 | US11524940, Compound 59...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582711(US11524940, Compound 727)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582712(US11524940, Compound 729 (Isomer 1))
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582709(US11524940, Compound 723 (Isomer 2))
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509959(US11124497, Compound 725 | US11524940, Compound 72...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582716(US11524940, Compound 733 (Isomer 2) | US11524940, ...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582714(US11524940, Compound 731 (Isomer 1))
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509964(US11124497, Compound 737 | US11524940, Compound 79...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509965(US11124497, Compound 739 | US11524940, Compound 73...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM509963(US11124497, Compound 735 | US11524940, Compound 73...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM550994(US11524940, Compound 743 (Isomer 2) | US11312704, ...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM420298(WO2005113580-Ex-02 | PF-00835231 | PF-0835231 | cm...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
Ligand InfoPurchaseSimilars
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
Pardes Biosciences

US Patent
LigandPNGBDBM582696(US11524940, Compound 667)
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds are assayed using standard methods to assess compound activity and IC50. As an exemplary for assessment of the SARS-COV2 Mpro, the C-His6-t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

Displayed 1 to 50 (of 342 total ) | Next | Last >>
Jump to: